drugset / Trial / NCT01099579
PRINCE: Study of Atazanavir (ATV)/Ritonavir (RTV)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether atazanavir powder combined with ritonavir is safe and well tolerated and produces appropriate drug exposure in children ≥3 months to \<6 years of age.
Timeline
- Start
- 2010-10-13
- Primary completion
- 2012-10-04
- Completion
- 2017-09-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atazanavir | Other / unclassified | 150 mg | Oral |
| Subject | Atazanavir | Other / unclassified | 200 mg | Oral |
| Subject | Atazanavir | Other / unclassified | 250 mg | Oral |
| Subject | Atazanavir | Other / unclassified | 300 mg | Oral |
| Background | Ritonavir | Other / unclassified | 80 mg | Oral |
| Background | Ritonavir | Other / unclassified | 100 mg | Oral |